The Interconnections of Mal de Débarquement Syndrome and Vestibular Migraine

Laryngoscope. 2021 May;131(5):E1653-E1661. doi: 10.1002/lary.29214. Epub 2020 Nov 2.

Abstract

Objectives/hypothesis: Mal de débarquement syndrome (MDDS) is characterized by a persistent rocking sensation, as though on a boat. It may occur following exposure to passive motion (motion-triggered MDDS [MT-MDDS]), or spontaneously (spontaneous-onset MDDS [SO-MDDS]). This study investigated the characteristics of MDDS patients with vestibular migraine (MDDS-VM) to those without (MDDS-O).

Study design: Retrospective review.

Methods: Retrospective, single-center study of 62 patients with MDDS. Clinical characteristics, Dizziness Handicap Inventory (DHI), Migraine Disability Assessment Score (MIDAS), job impact, and optimal treatment(s) were studied.

Results: There were 23 MDDS-O (19 women), and 39 MDDS-VM (35 women) patients. Comparisons between MDDS-VM and MDDS-O showed significant differences in age of onset (41 vs. 52 years, P = .005), interictal visually induced dizziness (89.7% vs. 30.4%, P < .001), interictal head motion-induced dizziness (87.2% vs. 47.8%, P = .001), other vestibular sensations (59% vs. 13%, P < .001), interictal aural symptoms (25.6% vs. 0%, P = .008), number of interictal symptoms (4.3 vs. 2.3, P < .001), total DHI score (54.9 vs. 38.1, P = .005), DHI-P (physical domain) score (16.1 vs. 10, P = .004), DHI-F (functional domain) score (20.9 vs. 15.7, P = .016 MIDAS (4.6 vs. 32, P = .002), and job resignations (23.2% vs. 5%, P = .016). On the other hand, between-group comparisons for MT-MDDS and SO-MDDS did not reveal any significant differences whatsoever. For optimal treatment, venlafaxine was the most used (27.3%) in all groups. For MDDS-VM, antiepileptic drugs and migraine preventive vitamins were also useful in relieving symptoms.

Conclusions: MDDS-VM patients appear to be more disabled than MDDS-O, in terms of severity of dizziness, job impact, and number of symptoms, but have good potential for improvement, particularly with migraine prophylactic treatment.

Level of evidence: 3 Laryngoscope, 131:E1653-E1661, 2021.

Keywords: dizziness; mal de débarquement syndrome; migraine; vertigo; vestibular migraine.

MeSH terms

  • Adult
  • Aged
  • Disability Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Migraine Disorders / complications
  • Migraine Disorders / diagnosis*
  • Migraine Disorders / drug therapy
  • Retrospective Studies
  • Severity of Illness Index*
  • Travel-Related Illness*
  • Venlafaxine Hydrochloride / therapeutic use*
  • Vestibular Diseases / complications
  • Vestibular Diseases / diagnosis*
  • Vestibular Diseases / drug therapy

Substances

  • Venlafaxine Hydrochloride

Supplementary concepts

  • Mal de debarquement